Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic.
about
Multiple myeloma in the older adult: better prospects, more challenges.Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesisPatient, Physician and Contextual Factors Are Influential in the Treatment Decision Making of Older Adults Newly Diagnosed with Symptomatic Myeloma.Effectiveness of targeted therapy as monotherapy or combined therapy in patients with relapsed or refractory multiple myeloma: a systematic review and meta-analysis.Second malignancies after multiple myeloma: from 1960s to 2010s.Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis.Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends.History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study.Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial.Managing multiple myeloma in the elderly: are we making progress?Efficacy and safety of busulfan-based conditioning regimens for multiple myelomaOptimizing quality of life in multiple myeloma patients: current options, challenges and recommendations.International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents.Novel investigational drugs active as single agents in multiple myeloma.The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based studyLatent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.Management of Elderly Patients with Plasma Cell Myeloma.Aging: Treating the Older Patient.Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression.Pleural Effusion in Multiple Myeloma: Characteristics and Practice Patterns.Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy.Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study.Clinical features and treatment outcome of very elderly patients over 80 years old with multiple myeloma: comparison with patients in different age groups in the era of novel agents.Gradual increase of chronic lymphocytic leukemia incidence in Korea, 1999-2010: comparison to plasma cell myeloma.Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune ProfilingInvasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies.Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era.Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response?Clinical risk factors of Plasmacytoma mortality: a US population-based study.Cancer incidence in Canada: trends and projections (1983–2032).Outcome and survival of myeloma patients diagnosed 2008-2015. Real world data on 4904 patients from the Swedish Myeloma Registry (SMR).Pre-existing diabetes mellitus in patients with multiple myeloma.Treat or palliate: outcomes of very elderly myeloma patients.Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project.Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents.Real life management of patients hospitalized with multiple myeloma in France.Multiple myelomaA Case of Multiple Myeloma Associated with Extramedullary Plasmacytoma of the Gallbladder Manifesting as Acute Cholecystitis
P2860
Q34031129-11502D6F-750B-4BA3-A704-4266498D8D06Q34411693-079B5E4A-14C7-410E-8063-18D09945D98CQ34781514-B7411453-8E16-463D-8F99-3864F079143EQ35104606-25C044E2-C6E9-4524-A12C-6CFCC91826C5Q35891594-035C21C6-7B9F-4411-829C-089B6E1549EBQ36115615-4B9ED8D2-FCBE-4454-BD8E-653E51F1A69BQ36526751-C90EA000-BEDF-407F-A72A-3A680E7D65A4Q37580855-C2A74DDC-C93D-4AE4-A085-30BA1B09D6DCQ37664019-26BAFB4B-A3AA-4C9C-85A7-8A78654854DCQ37888716-3235BE95-ED67-410D-93E5-0C43A8CC6391Q38102892-FF7C2FEB-78F1-4179-9E94-5CC0949FB58AQ38367654-1DFD1388-94B1-41AB-807D-B099826D946FQ38438670-7BD517F8-26C2-4F88-8482-066399F7DD89Q38690290-C7ED4C5E-F925-49AE-8E7F-2B133447EABBQ38714291-A16B6271-BD5C-40D3-B5F7-63C068C4218BQ38789129-498FD3CA-F7E9-4631-BD9B-00BAB0ACF5C2Q39001325-F24A0AA8-BD97-429A-85CC-3BBE8094E9A2Q39013605-576AED29-C86C-46D5-83EB-64DE25D47AE7Q39640777-04695439-E835-415A-9968-DC71AD110E23Q40098572-00510C4A-E9CD-4B03-915A-BD7635FC6414Q40150284-5A048AD4-D50C-409D-8744-71BF4A69F779Q40561960-8A4C403F-0A2C-4DCF-BD99-0B5DA9257FA8Q41605875-3E87A7F0-EC84-4866-A7D8-E6683B605322Q41622165-B5A6BDF2-367C-4036-8B00-2D5757E3E3BCQ42373431-9125C7D3-97A8-4A4C-9CF2-8C8E38FB3651Q43087338-1D8CEB9F-A922-425F-AF0C-3A12ADF253D4Q44156581-26537CD7-F363-4711-9E06-721DB1097EC6Q44956731-68452039-8E61-4CF5-AD74-D56FD63C1D67Q45266225-9D734F84-3965-46E1-A4A4-DFBE84D4A02CQ46495297-59C02AEA-DC74-4B76-857D-81D43F3FC608Q47198067-41A9594F-FBEA-42DD-A22A-D7C225E8006DQ48651168-C16F8ED4-A89E-40F3-AABF-0B30059DB28FQ49868035-7089C472-7E87-4093-8486-E5221C21C5A3Q50145894-53811B86-3CAD-4FA1-8F95-B8023659E655Q53811677-9E650E7F-0174-4C21-8B39-74A88C4DC1F4Q54941675-062FD284-CE1E-45CF-A023-F4E2919BA4A8Q56657250-B2FB8EE1-37CC-4936-9501-E05A58F70806Q57652872-7F0F45CC-B8B3-475C-8C84-73393A25EBDC
P2860
Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Patterns of multiple myeloma d ...... ge distribution in the clinic.
@ast
Patterns of multiple myeloma d ...... ge distribution in the clinic.
@en
type
label
Patterns of multiple myeloma d ...... ge distribution in the clinic.
@ast
Patterns of multiple myeloma d ...... ge distribution in the clinic.
@en
prefLabel
Patterns of multiple myeloma d ...... ge distribution in the clinic.
@ast
Patterns of multiple myeloma d ...... ge distribution in the clinic.
@en
P2093
P2860
P356
P1476
Patterns of multiple myeloma d ...... ge distribution in the clinic.
@en
P2093
Ingemar Turesson
Ramon Velez
Sigurdur Y Kristinsson
P2860
P304
P356
10.4065/MCP.2009.0426
P407
P50
P577
2010-03-01T00:00:00Z